Gopalakrishnan B - Search Results

1

Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).

Thilagavathi R, Kumar R, Aparna V, Sobhia ME, Gopalakrishnan B, Chakraborti AK. Thilagavathi R, et al. Among authors: gopalakrishnan b. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1027-32. doi: 10.1016/j.bmcl.2004.12.042. Bioorg Med Chem Lett. 2005. PMID: 15686906

2

Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.

Desiraju GR, Gopalakrishnan B, Jetti RK, Nagaraju A, Raveendra D, Sarma JA, Sobhia ME, Thilagavathi R. Desiraju GR, et al. Among authors: gopalakrishnan b. J Med Chem. 2002 Oct 24;45(22):4847-57. doi: 10.1021/jm020198t. J Med Chem. 2002. PMID: 12383010

3

3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors.

Chakraborti AK, Gopalakrishnan B, Sobhia ME, Malde A. Chakraborti AK, et al. Among authors: gopalakrishnan b. Bioorg Med Chem Lett. 2003 Apr 17;13(8):1403-8. doi: 10.1016/s0960-894x(03)00172-0. Bioorg Med Chem Lett. 2003. PMID: 12668000

4

Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.

Chakraborti AK, Gopalakrishnan B, Sobhia ME, Malde A. Chakraborti AK, et al. Among authors: gopalakrishnan b. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2473-9. doi: 10.1016/s0960-894x(03)00493-1. Bioorg Med Chem Lett. 2003. PMID: 12852946

5

3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors.

Chakraborti AK, Gopalakrishnan B, Sobhia ME, Malde A. Chakraborti AK, et al. Among authors: gopalakrishnan b. Eur J Med Chem. 2003 Nov-Dec;38(11-12):975-82. doi: 10.1016/j.ejmech.2003.09.001. Eur J Med Chem. 2003. PMID: 14642329

6

3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.

Aparna V, Jeevan J, Ravi M, Desiraju GR, Gopalakrishnan B. Aparna V, et al. Among authors: gopalakrishnan b. Bioorg Med Chem Lett. 2006 Feb 15;16(4):1014-20. doi: 10.1016/j.bmcl.2005.10.086. Epub 2005 Nov 15. Bioorg Med Chem Lett. 2006. PMID: 16290929

7

Insights into ligand selectivity in nitric oxide synthase isoforms: a molecular dynamics study.

Aparna V, Desiraju GR, Gopalakrishnan B. Aparna V, et al. Among authors: gopalakrishnan b. J Mol Graph Model. 2007 Sep;26(2):457-70. doi: 10.1016/j.jmgm.2007.02.003. Epub 2007 Feb 15. J Mol Graph Model. 2007. PMID: 17350298

8

Design of EGFR kinase inhibitors: a ligand-based approach and its confirmation with structure-based studies.

Vema A, Panigrahi SK, Rambabu G, Gopalakrishnan B, Sarma JA, Desiraju GR. Vema A, et al. Among authors: gopalakrishnan b. Bioorg Med Chem. 2003 Oct 15;11(21):4643-53. doi: 10.1016/s0968-0896(03)00482-6. Bioorg Med Chem. 2003. PMID: 14527561

9

Characterization of azithromycin hydrates.

Gandhi R, Pillai O, Thilagavathi R, Gopalakrishnan B, Kaul CL, Panchagnula R. Gandhi R, et al. Among authors: gopalakrishnan b. Eur J Pharm Sci. 2002 Aug;16(3):175-84. doi: 10.1016/s0928-0987(02)00087-8. Eur J Pharm Sci. 2002. PMID: 12128172

10

3-D-QSAR CoMFA and CoMSIA studies on tetrahydrofuroyl-L-phenylalanine derivatives as VLA-4 antagonists.

Khandelwal A, Narayanan R, Gopalakrishnan B. Khandelwal A, et al. Among authors: gopalakrishnan b. Bioorg Med Chem. 2003 Sep 15;11(19):4235-44. doi: 10.1016/s0968-0896(03)00408-5. Bioorg Med Chem. 2003. PMID: 12951154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters